Active Implantable Medical Devices (AIMD) Market - Forecasts from 2018 to 2023

Active Implantable Medical Devices (AIMD) Market - Forecasts from 2018 to 2023

The global Active Implantable Medical Devices (AIMD) market was  valued at US$20.204 billion in 2017, and is expected to register a CAGR of 7.12% to reach the value of US$30.520 billion in 2023. As per The Active Implantable Medical Device (AIMD) Directive, Active Implantable Medical Device is “any active medical device which is intended to be totally or partially introduced, surgically or medically, into the human body or by medical intervention into a natural orifice, and which is intended to remain after the procedure”. Implantable pacemaker, cochlear implants, ventricular assist devices, neurostimulators are some of the active implantable medical devices. Active implantable medical devices fall into highest risk categories of medical devices listing of the U.S. Food & Drug Administration (FDA). The growth in the market may be attributed to the rising prevalence of the cardiovascular and neurological disorders across the globe. Rising investments and funds by the companies to develop technologically advanced products will also boost the market for AIMD during the given forecast period. However, strict regulatory policies regarding the AIMD and high cost of the devices may restrain the market growth during the given time frame.

This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical region. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.

Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the global Active Implantable Medical Devices (AIMD) market value chain. Last step involves complete market engineering which includes analysing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.

Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the global Active Implantable Medical Devices (AIMD) market.

Major industry players profiled as part of the report are William Demant Holding A/S, Medtronic and Cochlear Ltd. among others.

Segmentation

By Product

Neurostimulators

Implantable Cardiac Pacemakers

Cochlear Implants

Ventricular assist devices

Others

 

By End-Users

Hospitals and Clinics

Ambulatory Surgical Centers

Specialty Clinics

 

By Geography

North America

United States

Canada

Others

 

South America

Brazil

Argentina

Others

 

Europe

United Kingdom

Germany

France

Others

 

Middle East and Africa

Saudi Arabia

UAE

Israel

Others

 

Asia Pacific

China

India

Australia

South Korea

Others

1. Introduction
1.1. Market Definition
1.2. Scope of the Study
1.3. Currency
1.4. Assumptions
1.5. Base, and Forecast Years Timeline
2. Research Methodology
2.1. Research Design
2.2. Secondary Sources
2.3. Validation
3. Key Findings of the Study
4. Market Dynamics
4.1. Drivers
4.2. Restraints
4.3. Opportunities and Market Trends
4.4. Market Segmentation
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Industry Value Chain Analysis
4.7. Industry Regulations
4.8. Scenario Analysis
5. Global Active Implantable Medical Devices (AIMD) Market Forecast by Product (US$ billion)
5.1. Neurostimulators
5.2. Implantable Cardiac Pacemakers
5.3. Cochlear Implants
5.4. Ventricular assist devices
5.5. Others
6. Global Active Implantable Medical Devices (AIMD) Market Forecast by End Users (US$ billion)
6.1. Hospitals and Clinics
6.2. Ambulatory Surgical Centers
6.3. Specialty Clinics
7. Global Active Implantable Medical Devices (AIMD) Market Forecast by Geography (US$ billion)
7.1. North America
7.1.1. The U.S
7.1.2. Canada
7.1.3. Mexico
7.1.4. Others
7.2. South America
7.2.1. Brazil 
7.2.2. Argentina
7.2.3. Others
7.3. Europe
7.3.1. U.K.
7.3.2. France
7.3.3. Germany
7.3.4. Italy
7.3.5. Others
7.4. Middle East and Africa
7.4.1. Saudi Arabia
7.4.2. UAE
7.4.3. Israel
7.4.4. Others
7.5. Asia Pacific 
7.5.1. China
7.5.2. India
7.5.3. Australia
7.5.4. South Korea
7.5.5. Others 
8. Competitive intelligence
8.1. Market Share Analysis
8.2. Strategies of Key Players
8.3. Recent Investments and Deals
9. Company Profiles
9.1. Abbott
9.1.1. Overview 
9.1.2. Financials
9.1.3. Product and Services 
9.1.4. Recent Developments
9.2. Medtronic
9.2.1. Overview 
9.2.2. Financials
9.2.3. Product and Services 
9.2.4. Recent Developments
9.3. Lifetech Scientific
9.3.1. Overview 
9.3.2. Financials
9.3.3. Product and Services 
9.3.4. Recent Developments
9.4. Boston Scientific Corporation
9.4.1. Overview 
9.4.2. Financials
9.4.3. Product and Services 
9.4.4. Recent Developments
9.5. BIOTRONIK SE & Co. KG
9.5.1. Overview 
9.5.2. Financials
9.5.3. Product and Services 
9.5.4. Recent Developments
9.6. Cochlear Ltd.
9.6.1. Overview 
9.6.2. Financials
9.6.3. Product and Services 
9.6.4. Recent Developments
9.7. MED-EL
9.7.1. Overview 
9.7.2. Financials
9.7.3. Product and Services 
9.7.4. Recent Developments
9.8. Advanced Bionics AG
9.8.1. Overview 
9.8.2. Financials
9.8.3. Product and Services 
9.8.4. Recent Developments
9.9. LivaNova PLC
9.9.1. Overview 
9.9.2. Financials
9.9.3. Product and Services 
9.9.4. Recent Developments
9.10. William Demant Holding A/S
9.10.1. Overview 
9.10.2. Financials
9.10.3. Product and Services 
9.10.4. Recent Developments
List of Figures
List of Tables

Abbott

Medtronic

Lifetech Scientific

Boston Scientific Corporation

BIOTRONIK SE & Co. KG

Cochlear Ltd.

MED-EL

Advanced Bionics AG

LivaNova PLC

William Demant Holding A/S

  • SKU:
  • Publishing Date: 2018-10-02
  • Product Code: 1
  • Availability: In Stock
  • $3,950.00
  • Ex Tax: $3,950.00

Available Options